The Global Research Awards for Nicotine Dependence
(GRAND) 2011
 
Advancing the Understanding of the Mechanisms
of Nicotine Dependence and Its Treatment
 
An Independent Competitive Grants Program
Supported by Pfizer  

The mission of the GRAND Program is to advance the understanding of the mechanisms of tobacco and nicotine dependence and its treatment.

  

The winners of the Global Research Awards for Nicotine Dependence
(GRAND) 2011 are announced, click here. 

 

Background
 
Scope of the Program for 2011 
 
Clinical research proposals should aim to increase the understanding of the mechanisms of tobacco and nicotine dependence and its treatment and fall into one of the following areas:
  • Human laboratory (e.g., pharmacokinetics, pharmacodynamics, cravings, withdrawal)
  • Pharmacotherapy of smoking cessation and relapse, and / or its interaction with behavioral support
  • Characterization of subtypes of smokers; suitability for appropriate interventions. 
      
Awards
 
The intent of the program is to fund at least 6 awards of between US $50,000 and US $200,000 in value, totaling US $1.2 million. These awards are open to all investigators. 
 
We strongly encourage applications from junior investigators.
 
Applications for 2011 closed on May 9, 2011.
 
 
 
For any questions regarding the 2011 GRAND Awards or future Grand Awards:
 
Phone: +1 215 239 6565
or: +44 1403 322 065
Email: enquiries@grand2011.org 
 
 

Links